DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Reinisch W, Sandborn WJ, Hommes DW et al.
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Gut 2011;
60: 780-787
We do not assume any responsibility for the contents of the web pages of other providers.